About
The Sebia gel technology is based on the principle of separating molecules in an agarose medium.
Three types of separation occur according to:
- The charge of the proteins, in a specific pH buffer
- The isoelectric point, in a specific pH gradient
- The molecular weight of the proteins, in an SDS-agarose gel
Sebia’s Expertise
With more than 50 years of experience in Gel Electrophoresis and more than 60 references, Sebia continues to develop and design the largest range of assays reaching the highest quality of standards.
The gel menu covers multiple pathologies including oncology (Multiple Myeloma), metabolic disorders such Hemoglobinopathies and rare pathologies in order to screen and monitor patients.
The multifunctional analyser HYDRASYS 2 SCAN FOCUSING allows simultaneous sample analyses on one gel. Coupled with the ASSIST sample application, migration, washing, staining and scanning are performed on-board automatically in order to quantify the protein fractions.
Sebia’s gel solutions gives you confidence when reporting your patients’ results with best-in-class gel electrophoresis assays.
Featured resources on Gel Electrophoresis
See all resourcesHYDRASHIFT avoids monoclonal antibody interference on IMMUNOFIXATION
The HYDRASHIFT portfolio include IVD test to mitigate interferences seen in immunofixation result for patient treated with isatuximab or daratumumab.
2017 Mc Donald Criteria for multiple sclerosis diagnosis
2017 Mc Donald Criteria for multiple sclerosis diagnosis includes CSF IgG oligoclonal bands.
2005 Multiple Sclerosis Consensus Criteria
2005 Multiple sclerosis consensus criteria includes CSF IgG oligoclonal bands.
Evaluation of a semi-automated von Willebrand factor multimer assay
Algorithm for congenital and acquired von Willebrand disease includes Hydragel vWF multimer analysis.
Improving diagnosis of von Willebrand disease
Multimer analysis to improve von Willebrand disease classification with Hydragel vWF multimer Sebia.
von Willebrand Factor and COVID-19
Correlation of von Willebrand factor with the severity of COVID-9 progression.
von Willebrand Disease Classification
There are three types of von Willebrand Disease. In this leaflet, different cases from congenital and acquired VWD are presented.
Evaluation of Sebia’s isoelectrofocusing kit for A1AT
Evaluation of Sebia’s isoelectrofocusing kit for A1AT with HYDRASYS.
Pitfalls and ceveats of A1AT diagnosis
Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.
Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab
Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.
Multiple Myeloma clinical cases for diagnosis and monitoring according to latest IMWG recommendations
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Performance of Immunotyping vs. Immunofixation for the Detection of Monoclonal Gammopathies
Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center
Early detection of Multiple Myeloma: The importance of serum protein electrophoresis
Educational Webinar with Dr. Julien GUILLEMAUD
Recommendations for the laboratory diagnosis of von Willebrand disease
Educational Webinar with Juliana A. Silva
Impact of monoclonal antibody therapies on electrophoresis interpretation in myeloma patients
Educational Webinar with Dr. Rachel WHEELER
The importance of SPE and A1AT phenotyping for a better AATD patient management
Educational Webinar Pr Simone Scarlata
AL Amyloidosis: Role of clinical lab in diagnosis and management
Educational Webinar with Prof. Giovanni PALLADINI, PhD
Upcoming events
See all eventsApr. 11, 2022 Nov. 21, 2024
IFCC Euromedlab 2021
Sebia booth: #121
Sebia Workshop: EduW22
Jun. 27, 2022 Jun. 29, 2022
IFCC Worldlab 2022
Sebia booth: #72
Sebia Workshop: EduW25
May. 22, 2023 May. 24, 2023
IFCC Euromedlab /WorldLab 2023
Sebia booth: #21
Sebia Workshop: EduW15
Apr. 18, 2024 Apr. 20, 2024
European Myeloma Network Meeting – EMN 2024
Sebia booth: #9
Serum and Urine Immunofixation
Identification of monoclonal proteins by agarose gel electrophoresis.
HYDRASHIFT
Avoid interferences due to therapeutic Monoclonal Antibody with HYDRASHIFT Portfolio.
Alpha 1-Antitrypsin (A1AT) Phenotype Testing*
The gold standard assay for the alpha 1-antitrypsin (A1AT) phenotype testing.
* Under Product Registration approval
CNS Local IgG synthesis detection by isoelectrofocusing
The gold standard assay to objectively detect CNS local IgG synthesis in multiple sclerosis.
von WILLEBRAND Multimer Analysis
Multimer assay simplified.
Hemoglobin disorders screening
The high-resolution method for hemoglobin disorders screening.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.